Dementia

Key Points

  • Dementia (major neurocognitive disorder) is progressive decline in cognition that impairs independence.
  • DSM-5 terminology favors major neurocognitive disorder instead of the older dementia label.
  • Alzheimer disease is most common (roughly 60-80% of cases), but multiple etiologies and subtypes exist.
  • Dementia burden is global, with tens of millions of affected people worldwide.
  • Differential diagnosis from delirium is essential because onset and treatment pathways differ.
  • Nursing care prioritizes safety, function support, caregiver education, and quality-of-life preservation.

Pathophysiology

Major neurocognitive disorders involve progressive neuronal dysfunction and loss, producing decline in memory, executive function, language, visuospatial ability, and social cognition. Course and symptom profile vary by etiology (for example Alzheimer, vascular, Lewy body, frontotemporal, Parkinson-associated).

Pathogenesis includes progressive loss of neuronal activity and inter-neuronal connectivity; this process is age-associated but disproportionately accelerated in major neurocognitive disorder compared with expected aging.

As decline advances, functional dependence and safety risk increase, requiring staged care adaptation. Dementia is generally gradual, progressive, and not reversible even though symptom-directed care can still improve safety and quality of life.

Because acute confusion may represent treatable medical illness, sudden cognitive change should trigger urgent delirium-oriented assessment rather than automatic dementia attribution.

Classification

  • Severity staging: Progressive levels from mild to very severe cognitive decline.
  • Reisberg-style progression landmarks:
    • Very mild to mild decline: Subtle memory/word-finding concerns with emerging work or complex-task difficulty.
    • Moderate to moderately severe decline: Worsening orientation, financial/travel difficulty, and increasing assistance needs.
    • Severe to very severe decline: Dependence in ADLs, incontinence, major communication decline, dysphagia/mobility loss, and full-care dependence.
  • Etiologic subtype: Alzheimer, vascular, Lewy body, frontotemporal, trauma/substance/medical-related, HIV-associated, prion-related, Parkinson-associated, Huntington-associated, mixed, and unknown forms.
  • Population context: Risk rises with advanced age, and prevalence is high in adults older than 85 years.
  • Subtype clinical signatures:
    • Vascular dementia often has more abrupt onset with faster decline than Alzheimer patterns and may show apraxia/agnosia features.
    • Lewy body dementia commonly includes fluctuating cognition, visual hallucinations, and sleep-motor disturbance.
    • Frontotemporal dementia often presents earlier (commonly 45-65 years) with behavior/language-predominant change.
  • Care context: Community support, assisted living, or skilled nursing based on function and safety.

Nursing Assessment

NCLEX Focus

Compare onset and fluctuation pattern to distinguish dementia from delirium.

  • Assess baseline cognition, progression timeline, and ADL/IADL performance.
  • Differentiate chronic dementia decline from acute delirium and from depression-related cognitive slowing that can mimic dementia.
  • Compare differential features directly: dementia usually has insidious onset with chronically reduced cognition, whereas delirium usually has abrupt onset with fluctuating attention/alertness and variable psychomotor activity.
  • Assess behavioral symptoms (agitation, wandering, sleep disruption, communication changes).
  • Review medication and comorbidity context that can worsen cognitive function (for example anticholinergic or opioid burden, head injury, cardiovascular disease, Parkinson patterns, and immune disorders).
  • Assess home environment hazards and supervision needs.
  • Assess caregiver strain, coping, and support-service gaps.
  • Assess comorbid medical needs that may worsen cognitive decline.

Diagnostic and Monitoring Data

  • Diagnostic workup may include cognitive-neurologic testing, CT/MRI brain imaging, PET brain-metabolism assessment, and lumbar puncture in selected etiologic-differential pathways.
  • CT/MRI and PET data are often used both to detect neurodegenerative patterns and to exclude competing structural/vascular causes of decline.
  • CSF testing may support etiologic clarification in selected major neurocognitive presentations.
  • Use serial screening benchmarks (for example Mini-Cog with clock-drawing components) to trend decline over follow-up intervals.

Nursing Interventions

  • Use calm, simple communication and consistent routines to reduce distress.
  • Adapt environment for orientation and safety (lighting, cues, fall prevention, exit safety).
  • Support person-centered care and avoid confrontational reorientation when harmful.
  • Build daily routines with familiar, purposeful activities (for example folding towels or simple role-consistent tasks) to reduce anxiety and improve participation.
  • Coordinate interdisciplinary planning for medications, function support, and placement needs.
  • Use team-based care planning with provider, pharmacist, social worker, nurse, and family/caregivers to align diagnosis follow-up, medication strategy, and support services.
  • Support medication adherence to symptom-management therapies (for example cholinesterase-inhibitor and memantine pathways) and monitor tolerance.
  • Coordinate OT and structured exercise planning when function permits to support safety and preserve cognition-linked independence.
  • Provide caregiver coaching, respite-service linkage, and anticipatory guidance.
  • When home care burden exceeds family capacity, coordinate referrals to local aging/disability resource programs, adult day services, home-health support, assisted-living or residential options, and skilled nursing placement as indicated.

One-Size-Fits-All Approach

Applying uniform interventions across dementia subtypes can worsen symptoms and caregiver burden.

Pharmacology

Medication may provide symptom support in selected subtypes (for example cognitive enhancers and targeted behavioral treatments), but nursing monitoring for effectiveness, adverse effects, and functional impact remains essential.

Clinical Judgment Application

Clinical Scenario

An older adult with gradual memory loss, getting lost in familiar places, and reduced medication self-management is brought by family after two recent near-falls.

  • Recognize Cues: Progressive cognitive and functional decline with immediate safety concerns.
  • Analyze Cues: Pattern is consistent with major neurocognitive disorder rather than acute delirium.
  • Prioritize Hypotheses: Priority is home safety stabilization and structured long-term care planning.
  • Generate Solutions: Initiate dementia-focused assessment, caregiver support, and environment modifications.
  • Take Action: Coordinate interdisciplinary plan and community support referrals.
  • Evaluate Outcomes: Track safety events, caregiver burden, and function trajectory.